Aprea Therapeutics, Inc. (APRE)
Operating Cash Flow (Statement)
-$3.28M
Quarterly · Period ending: · USD
APRE Operating Cash Flow (Statement)
Latest reported-$3.28Mperiod ending
Latest reported-$3.28Mperiod ending
APRE Quarterly Cash from Operations (-$3.15M → -$3.28M)
Quarterly operating cash flow (statement)
High-resolution chart · PNG
APRE operating cash flow (statement) history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -3,278,763 | |
| -2,756,726 | |
| -2,961,292 | |
| -3,171,230 | |
| -3,130,754 | |
| -3,631,163 | |
| -3,510,904 | |
| -2,468,302 | |
| -3,641,621 | |
| -3,935,891 | |
| -3,739,658 | |
| -2,241,965 | |
| -3,216,904 | |
| -2,979,081 | |
| -4,020,512 | |
| -6,592,682 | |
| -8,902,613 | |
| -5,495,329 | |
| -10,178,787 | |
| -8,233,404 | |
| -7,751,883 | |
| -11,522,106 | |
| -13,199,202 | |
| -13,158,125 | |
| -9,638,313 | |
| -7,541,625 | |
| -10,429,445 | |
| -6,412,966 | |
| -5,600,097 | |
| -4,197,346 | |
| -3,851,269 | |
| -3,152,131 |